Your browser doesn't support javascript.
Idiopathic systemic capillary leak syndrome: a case report.
Lee, Hyang-Yun; Shin, Jungho; Kim, Su-Hyun; Hwang, Jin Ho.
  • Lee HY; Division of Nephrology, Department of Internal Medicine, Chung-Ang University Hospital, Seoul, Korea.
  • Shin J; Division of Nephrology, Department of Internal Medicine, Chung-Ang University Hospital, Seoul, Korea.
  • Kim SH; Department of Internal Medicine, Chung-Ang University College of Medicine, Chung-Ang University Hospital, 102, Heukseok-Ro, Dongjak-Gu, Seoul, 06973, Republic of Korea.
  • Hwang JH; Department of Internal Medicine, Chung-Ang University College of Medicine, Chung-Ang University Hospital, 102, Heukseok-Ro, Dongjak-Gu, Seoul, 06973, Republic of Korea.
BMC Nephrol ; 24(1): 72, 2023 03 25.
Article in English | MEDLINE | ID: covidwho-2268248
ABSTRACT

BACKGROUND:

Idiopathic systemic capillary leak syndrome (ISCLS) is a rare disease characterized by recurrent episodes of acute life-threatening attacks of shock, hemoconcentration, and hypoalbuminemia. Increase in capillary permeability results in reversible plasma movement into the interstitial spaces followed by appearance of related symptoms or complications, including renal failure. This condition can be potentially life-threatening; however, it is easily misdiagnosed. CASE PRESENTATION A 47-year-old man with no previous medical history presented to the emergency department after experiencing general weakness and abdominal pain. He developed hypovolemic shock within 3 h of presentation and initial laboratory tests showed hemoconcentration, hypoalbuminemia and acute kidney injury. Following vigorous fluid therapy and supportive care, the patient recovered, but a similar episode recurred after 4 months without any specific trigger. Based on the combined clinical manifestations and laboratory findings of both the attacks, he was diagnosed with ISCLS. Symptomatic relief was achieved via oxygen supplementation and massive volume replacement using normal saline and the patient was prescribed bambuterol 10 mg and theophylline 400 mg once-a-day. He was discharged from the hospital on day 5 of hospitalization. Thereafter, the patient has been followed for 5 years without any symptoms or recurrence of ISCLS even in the situation of COVID-19 infection.

CONCLUSIONS:

ISCLS is an extremely infrequent and commonly misdiagnosed disease. However, early diagnosis, treatment and prophylaxis through accumulated clinical data can prevent ISCLS recurrence and the development of related fatal complications. Therefore, clinicians need to be well aware of the variety of clinical characteristics and treatment options of this disease.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Capillary Leak Syndrome / Hypoalbuminemia / COVID-19 Type of study: Case report / Diagnostic study / Prognostic study Topics: Long Covid Limits: Humans / Male / Middle aged Language: English Journal: BMC Nephrol Journal subject: Nephrology Year: 2023 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Capillary Leak Syndrome / Hypoalbuminemia / COVID-19 Type of study: Case report / Diagnostic study / Prognostic study Topics: Long Covid Limits: Humans / Male / Middle aged Language: English Journal: BMC Nephrol Journal subject: Nephrology Year: 2023 Document Type: Article